METAVIA INC. Other Current Liabilities
METAVIA INC. (MTVA) had Other Current Liabilities of $1.90 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Current $1.90M.
- 2026-03-31: Other Liabilities, Current $3.01M.
- 2025-12-31: Other Liabilities, Current $3.31M.
- 2025-09-30: Other Liabilities, Current $3.32M.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $1.90M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.01M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.31M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $3.32M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.67M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.38M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.47M 10-K · filed 2026-03-26 |
| 2024-09-30 | $3.45M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.62M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $789.00K 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |